Physician profile
Michael L Bernard
NPI 1346356458
$1,399.40
in general payments reported to CMS, 2019-2025
12 companies · $72.48 in 2025
The $72.48 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.40 · 2020: $913 · 2021: $57.72 · 2022: $122 · 2023: $132 · 2024: $23.32 · 2025: $72.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $900.00 | 2020 | |
| Smith+Nephew, INC. | $123.71 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Boston Scientific Corporation | $75.41 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Kestra Medical Technology Services, INC. | $72.48 | 2025 | Assure Wcd |
| Stryker Corporation | $57.72 | 2021 | |
| Janssen Biotech, INC. | $40.73 | 2023 | Remicade, Simponi Aria, Stelara |
| Heron Therapeutics, INC. | $38.80 | 2022-2023 | Zynrelef |
| Acacia Pharma INC | $26.64 | 2022 | |
| Abbott Laboratories | $23.79 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.87 | 2019 | |
| Merck Sharp & Dohme LLC | $12.81 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.